29/04/2026
‼️MEDICATION RECALL ALERT – SERTRALINE 100MG
We have been made aware of the following recall of Sertraline 100mg. Please ensure you read the information below carefully and check your medications accordingly if you are currently prescribed this item.
Sertraline and citalopram are both selective serotonin reuptake inhibitors (SSRIs) used to treat depression, anxiety disorders, and related mental health conditions by boosting brain serotonin.
Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site, where it was identified that a pack of Sertraline 100 mg film-coated tablets (Batch Number V2500425) contains one blister strip of Citalopram 40 mg film-coated tablets inside the sealed carton. Both products were manufactured at the same manufacturing site and the error appears to have occurred during secondary packaging of the blister strips into the cartons.
Some cartons of Sertraline 100 mg film-coated tablets, manufactured by Amarox Limited, may contain a blister strip(s) of Citalopram 40 mg tablets. All packs of Sertraline 100 mg film-coated tablets, Batch Number V2500425, are being recalled as a precautionary measure.
If you have been prescribed Sertraline 100 mg film-coated tablets and have received impacted product (Batch Number V2500425), please check that the carton contains the correct medication. The batch number and expiry date can be found printed on the side of the outer carton.
• If the carton contains blister strips that are labelled and contain Citalopram 40 mg film-coated tablets, contact your dispensing pharmacy in the first instance.
• If the carton contains blister strips that are labelled and contain Sertraline 100 mg film-coated tablets, you do not need to take further action.
If you have an impacted pack or previously received this batch, (where known) and you believe you have taken the Citalopram 40 mg film-coated tablets that were included in error and are currently experiencing any side effects, then please seek immediate medical advice.
Please take the leaflet that came with your medicine and any remaining tablets with you to your pharmacy or GP practice. If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals responsible for your care.
Both sertraline and citalopram are used to treat depression and anxiety; however, as your body may not be accustomed to citalopram, you may experience most common possible side effects such as nausea, headache, sleep changes and mild anxiety.
The description of the tablets from the Patient Information Leaflets (PILs) are as follows:
• Sertraline 100 mg film-coated tablets: White to off white, film-coated, capsule shaped biconvex tablets and debossed with ‘3 and 1’ on either side of score line on one side and “HS” on other side.
• Citalopram 40 mg film-coated tablets: White to off-white coloured, film coated, oval biconvex tablets, debossed with “Z and 9” on either side of the score line and “H” on the other side.
Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
